Literature DB >> 17663862

[Creatinine clearance and contrast nephropathy in patients with normal creatinine levels].

José A de Agustín1, Rocío Carda, María del C Manzano, Borja Ruiz-Mateos, Juan C García-Rubira, Antonio Fernández-Ortiz, Isidre Vilacosta, Carlos Macaya.   

Abstract

The main risk factor for contrast nephropathy is the presence of poor renal function. Plasma creatinine level is not a reliable measure of renal function as its value could lie within the normal range despite the presence of significant nephropathy. The purpose of this study was to evaluate the creatinine clearance rate as a predictor of contrast nephropathy in patients with a normal plasma creatinine level. The study included 273 consecutive patients with non-ST elevation acute coronary syndrome (NSTEACS) and a normal plasma creatinine level at admission who underwent coronary angiography. Patients who developed contrast nephropathy had a lower creatinine clearance rate at admission (66.3 mL/min vs. 83.4 mL/min; P<.001). A creatinine clearance rate < 80 mL/min had a sensitivity of 81% for predicting contrast nephropathy. Creatinine clearance should be measured routinely in patients with NSTEACS who are scheduled for coronary angiography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17663862

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  2 in total

1.  Comparison of magnetic wire navigation with the conventional wire technique for percutaneous coronary intervention of chronic total occlusions: a randomised, controlled study.

Authors:  Christian Roth; Rudolf Berger; Sabine Scherzer; Lisa Krenn; Clemens Gangl; Daniel Dalos; Georg Delle-Karth; Thomas Neunteufl
Journal:  Heart Vessels       Date:  2015-09-14       Impact factor: 2.037

2.  Substantial iodine volume load reduction in CT angiography with dual-energy imaging: insights from a pilot randomized study.

Authors:  Patricia Carrascosa; Carlos Capunay; Gaston A Rodriguez-Granillo; Alejandro Deviggiano; Javier Vallejos; Jonathon A Leipsic
Journal:  Int J Cardiovasc Imaging       Date:  2014-07-23       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.